Fake Lipitor lingers in supply chain

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has reissued its safety warning after it was discovered that a recall in July 2005 of batch 004405K1 of Lipitor 20mg tablets had left some fake tablets with pharmacists.

These tablets contain lovastatin as an active ingredient as opposed to atorvastatin, though both statins have a similar effect of lowering cholesterol and the effect on patients is considered negligible.

By Gregory Roumeliotis
24 July 2006

Read the full story at in-pharmatechnologist.com.